Neovacs SA (0LW0) Stock Statistics & Valuation Metrics

Neovacs SA has a market cap or net worth of €763.00. The enterprise value is -€204.31K.

Neovacs SA has 476,625 shares outstanding. The number of shares has decreased by -2.65% in one year.

Neovacs SA’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -14.12%.

The current PE Ratio of Neovacs SA is ―. Neovacs SA’s PEG ratio is 0.05.

In the last 12 months, Neovacs SA had revenue of 533.41K and earned -8.74M in profits. Earnings per share was -249.00K.

In the last 12 months, operating cash flow was -1.47M and capital expenditures -218.92K, giving a free cash flow of -1.68M billion.

Neovacs SA pays an annual dividend of ―, resulting in a dividend yield of ―

Neovacs SA upcoming earnings date is Mar 30, 2026, Before Open (Confirmed).

Neovacs SA as a current ratio of 1.03, with Debt / Equity ratio of ―

In the past 12 months, Neovacs SA has paid -876.76K in taxes.

Neovacs SA EV to EBITDA ratio is -83.22, with an EV/FCF ratio of -332.21.

Neovacs SA has €231.61K in cash and marketable securities with €230.37K in debt, giving a net cash position of -€249.01K billion.

Gross margin is ―, with operating margin of -1294.97%, and net profit margin of -1639.16%.

The average price target for Neovacs SA is ―, which is 11.43% higher than the current price. The consensus rating is ―